These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 25237461)
1. The real practice of antibiotic prophylaxis for prostate biopsy in Korea where the prevalence of quinolone-resistant Escherichia coli is high. Kim DH; Bae SR; Choi WS; Park HK; Paick SH; Kim HG; Loh YS Korean J Urol; 2014 Sep; 55(9):593-8. PubMed ID: 25237461 [TBL] [Abstract][Full Text] [Related]
2. Incidence and management of extended-spectrum beta-lactamase and quinolone-resistant Escherichia coli infections after prostate biopsy. Song W; Choo SH; Sung HH; Han DH; Jeong BC; Seo SI; Jeon SS; Lee KS; Lee SW; Lee HM; Choi HY; Jeon HG Urology; 2014 Nov; 84(5):1001-7. PubMed ID: 25443894 [TBL] [Abstract][Full Text] [Related]
3. Fluoroquinolone-resistant Escherichia coli among the rectal flora is the predominant risk factor for severe infection after transrectal ultrasound-guided prostate biopsy: a prospective observational study. Holmbom M; Forsberg J; Fredrikson M; Nilsson M; Nilsson LE; Hanberger H; Hällgren A Scand J Urol; 2023 Aug; 58():32-37. PubMed ID: 37553957 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of Complications Leading to a Health Care Contact After Transrectal Prostate Biopsies: A Prospective, Controlled, Multicenter Study Based on a Selected Study Cohort. Knaapila J; Gunell M; Syvänen K; Ettala O; Kähkönen E; Lamminen T; Seppänen M; Jambor I; Rannikko A; Riikonen J; Munukka E; Eerola E; Hakanen AJ; Boström PJ Eur Urol Focus; 2019 May; 5(3):443-448. PubMed ID: 29275146 [TBL] [Abstract][Full Text] [Related]
5. Antibiotic susceptibility of intestinal Escherichia coli in men undergoing transrectal prostate biopsies: a prospective, registered, multicentre study. Knaapila J; Kallio H; Hakanen AJ; Syvänen K; Ettala O; Kähkönen E; Lamminen T; Seppänen M; Jambor I; Rannikko A; Riikonen J; Munukka E; Eerola E; Gunell M; Boström PJ BJU Int; 2018 Aug; 122(2):203-210. PubMed ID: 29533507 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of fluoroquinolone-resistant rectal flora in patients undergoing transrectal ultrasound-guided prostate needle biopsy: A prospective multicenter study. Chung HS; Hwang EC; Yu HS; Jung SI; Lee SJ; Lim DH; Cho WJ; Choe HS; Lee SJ; Park SW Int J Urol; 2018 Mar; 25(3):278-283. PubMed ID: 29241300 [TBL] [Abstract][Full Text] [Related]
7. Selective culture of Escherichia coli to prevent infective complications of transrectal ultrasound-guided prostate biopsy: Clinical efficacy and analysis of characteristics of quinolone-resistant Escherichia coli. Hiyama Y; Takahashi S; Uehara T; Ichihara K; Hashimoto J; Matsukawa M; Taguchi K; Kunishima Y; Hotta H; Yanase M; Itoh N; Hirose T; Takeyama K; Tachiki H; Masumori N Int J Urol; 2019 Jun; 26(6):655-660. PubMed ID: 30959574 [TBL] [Abstract][Full Text] [Related]
8. Clinical Importance of Antibiotic Regimen in Transrectal Ultrasound-Guided Prostate Biopsy: A Single Center Analysis of Nine Thousand Four Hundred Eighty-Seven Cases. Seo YE; Ryu H; Oh JJ; Jeong SJ; Hwang SI; Lee HJ; Hong SK; Byun SS; Lee SE; Lee S Surg Infect (Larchmt); 2018 Oct; 19(7):704-710. PubMed ID: 30227106 [TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of standard vs intensive antibiotic regimens for transrectal ultrasonography (TRUS)-guided prostate biopsy prophylaxis. Adibi M; Pearle MS; Lotan Y BJU Int; 2012 Jul; 110(2 Pt 2):E86-91. PubMed ID: 22115356 [TBL] [Abstract][Full Text] [Related]
10. Antibiotic prophylaxis with intravenous ceftriaxone and fluoroquinolone reduces infectious complications after transrectal ultrasound-guided prostatic biopsy. Lee C; You D; Jeong IG; Hong JH; Choo MS; Ahn H; Ahn TY; Kim CS Korean J Urol; 2015 Jun; 56(6):466-72. PubMed ID: 26078845 [TBL] [Abstract][Full Text] [Related]
11. Infection after transrectal ultrasound-guided prostate biopsy. Lee SJ Korean J Urol; 2015 May; 56(5):346-50. PubMed ID: 25964834 [TBL] [Abstract][Full Text] [Related]
12. Infectious complications following transrectal ultrasound-guided prostate biopsy: new challenges in the era of multidrug-resistant Escherichia coli. Williamson DA; Barrett LK; Rogers BA; Freeman JT; Hadway P; Paterson DL Clin Infect Dis; 2013 Jul; 57(2):267-74. PubMed ID: 23532481 [TBL] [Abstract][Full Text] [Related]
13. Antibiotic prophylaxis for transrectal ultrasound biopsy of the prostate in Ireland. Smyth LG; Mulvin DW Ir J Med Sci; 2012 Mar; 181(1):33-5. PubMed ID: 22057660 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of ciprofloxacin-resistant Enterobacteriaceae in the intestinal flora of patients undergoing transrectal prostate biopsy in Norwich, UK. Hanna MY; Tremlett C; Josan G; Eltom A; Mills R; Rochester M; Livermore DM BJU Int; 2015 Jul; 116(1):131-4. PubMed ID: 25079680 [TBL] [Abstract][Full Text] [Related]
16. Guidelines for Transrectal Ultrasonography-Guided Prostate Biopsy: Korean Society of Urogenital Radiology Consensus Statement for Patient Preparation, Standard Technique, and Biopsy-Related Pain Management. Lee MS; Moon MH; Kim CK; Park SY; Choi MH; Jung SI; Korean J Radiol; 2020 Apr; 21(4):422-430. PubMed ID: 32193890 [TBL] [Abstract][Full Text] [Related]
17. Extended-spectrum β-lactamase in the rectal flora of patients undergoing transrectal prostate biopsy: a study of the prevalence in a major metropolitan hospital. Sewell J; Chow K; De Sousa A; Sapre N; Norris B; Namdarian B; Sinickas V; Huang JG; Anderson P BJU Int; 2019 May; 123 Suppl 5():43-46. PubMed ID: 31012990 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of combined prophylactic use of levofloxacin and isepamicin for transrectal prostate needle biopsy: A retrospective single-center study. Nakagawa R; Shigehara K; Aoyama S; Urata S; Ofude M; Miyagi T; Nakashima T; Izumi K; Mizokami A J Infect Chemother; 2019 May; 25(5):337-340. PubMed ID: 30718193 [TBL] [Abstract][Full Text] [Related]
19. Escherichia coli bloodstream infection after transrectal ultrasound-guided prostate biopsy: implications of fluoroquinolone-resistant sequence type 131 as a major causative pathogen. Williamson DA; Roberts SA; Paterson DL; Sidjabat H; Silvey A; Masters J; Rice M; Freeman JT Clin Infect Dis; 2012 May; 54(10):1406-12. PubMed ID: 22419681 [TBL] [Abstract][Full Text] [Related]
20. Comparative Effectiveness of Single versus Combination Antibiotic Prophylaxis for Infections after Transrectal Prostate Biopsy. Marino K; Parlee A; Orlando R; Lerner L; Strymish J; Gupta K Antimicrob Agents Chemother; 2015 Dec; 59(12):7273-5. PubMed ID: 26369958 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]